Filana Therapeutics, Inc.
FLNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069530
In the last 90 days, Filana Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 85 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Filana Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +7 vs. Q3 2025
- Shares held
- 13.8M
- +183.8K (+1.4%) vs. Q3 2025
- Total value
- $27.3M
- −$12.3M (−31.0%) vs. Q3 2025
- New holders
- 22
- 24 more added
- Sold out
- 15
- 30 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FLNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 85 | $15.1M |
| Q1 2026 | 101 | $23.1M |
| Q4 2025 | 107 | $27.3M |
| Q3 2025 | 103 | $40.1M |
| Q2 2025 | 97 | $22.1M |
| Q1 2025 | 117 | $23.6M |
| Q4 2024 | 137 | $41.1M |
| Q3 2024 | 161 | $412.5M |
| Q2 2024 | 145 | $164.6M |
| Q1 2024 | 142 | $235.3M |
| Q4 2023 | 153 | $313.5M |
| Q3 2023 | 141 | $215.4M |
| Q2 2023 | 152 | $286.8M |
| Q1 2023 | 145 | $287.9M |
| Q4 2022 | 153 | $332.5M |
| Q3 2022 | 174 | $438.9M |
| Q2 2022 | 149 | $279.2M |
| Q1 2022 | 163 | $390.2M |
| Q4 2021 | 171 | $504.1M |
| Q3 2021 | 181 | $757.3M |
| Q2 2021 | 169 | $893.4M |
| Q1 2021 | 128 | $458.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Filana Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 528,018 | $1.05M | 0.00% | +146,000+38.2% | Added |
| Geode Capital Management, LLC | 545,969 | $1.08M | 0.00% | +8,068+1.5% | Added |
| Two Sigma Investments, LP | 642,401 | $1.27M | 0.00% | +77,403+13.7% | Added |
| Two Sigma Advisers, LP | 954,800 | $1.89M | 0.00% | −6,700−0.7% | Reduced |
| BlackRock, Inc. | 1,419,934 | $2.81M | 0.00% | +10,778+0.8% | Added |
| Marshall Wace, LLP | 2,115,307 | $4.19M | 0.00% | +54,021+2.6% | Added |
| Vanguard Group Inc | 2,375,589 | $4.70M | 0.00% | +86,066+3.8% | Added |
| GMT Capital Corp | 0 | $0 | 0.00% | −450,100−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −425,000−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −142,385−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −81,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −44,500−100.0% | Sold out |
| Brookstone Capital Management | 0 | $0 | 0.00% | −16,753−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,864−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,396−100.0% | Sold out |
| Eagle Wealth Strategies LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| AllSquare Wealth Management LLC | – | – | – | – | Not filed |